• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceLiverty™ TIPS Stent Graft
Generic NameSHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
ApplicantBard Peripheral Vascular, Inc.
1625 W. 3rd St.
Tempe, AZ 85281
PMA NumberP250050
Date Received11/26/2025
Decision Date09/25/2026
Product Code MIR 
Advisory Committee Cardiovascular
Clinical TrialsNCT05711316
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval for the Liverty™ TIPS Stent Graft. The device is indicated for the treatment of complications of portal hypertension
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Labeling Part 2
Post-Approval StudyShow Report Schedule and Study Progress
Supplements:  S001 
-
-